SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Grashoff Christopher L. (Last) (First) (Middle) C/O OPTION CARE HEALTH, INC. 3000 LAKESIDE DRIVE, SUITE 300N (Street) BANNOCKBURN IL 60015 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 12/06/2023	3. Issuer Name and Ticker or Trading Symbol Option Care Health, Inc. [ OPCH ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Growth Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	16,609(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(2)	02/23/2031	Common Stock	4,904	18.97	D
Employee Stock Option (right to buy)	(3)	10/21/2031	Common Stock	8,974	25.75	D
Employee Stock Option (right to buy)	(4)	02/17/2032	Common Stock	4,052	23.96	D
Employee Stock Option (right to buy)	(5)	02/22/2033	Common Stock	7,956	28.86	D

Explanation of Responses:

1. Includes (i) 4,332 restricted stock units that vest as to 25% of the underlying shares of Common Stock on each of February 22, 2024, February 22, 2025, February 22, 2026 and February 22, 2027, (ii) 5,193 restricted stock units that vest on May 19, 2024 (iii) 2,088 restricted stock units that vested as to 25% of the underlying shares of Common Stock on February 17, 2023 and that will vest as to 25% of the underlying shares of Common Stock on February 17, 2024, February 17, 2025 and February 17, 2026, (iv) 3,107 restricted stock units that vest on October 21, 2024, and (v) 2,504 restricted stock units that vested as to 50% of the underlying shares of Common Stock on February 23, 2023, and that will vest as to 25% of the underlying shares of Common Stock on each of February 23, 2024 and February 23, 2025.

2. 2,452 stock options vested on February 23, 2023; 1,226 stock options vest on February 23, 2024 and 1,226 vest on February 23, 2025.

3. Stock option vests in full on October 21, 2024.

4. 1,013 stock options vested on February 17, 2023; 1,013 stock options vest on February 17, 2024, 1,013 stock options vest on February 17, 2025 and 1,013 stock options vest on February 17, 2026.

5. Stock option vests in four equal annual installments starting on February 22, 2024.

Remarks:

Exhibit List: Exhibit 24-Power of Attorney

	/s/ Sarah Kim, attorney-in-fact for Mr. Grashoff	12/15/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

FOR SECTION 16 REPORTING OBLIGATIONS

 KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes
 and appoints each of Michael Shapiro, Sarah Kim and Michael Bavaro,
 signing singly, the undersigneds true and lawful attorney-in-fact to:
(i) execute for and on behalf of the undersigned, in the
 undersigneds capacity as an officer and/or director and/or owner of
 greater than 10% of the outstanding shares of common stock of
 Option Care Health, Inc., a Delaware corporation (the Company),
 Forms 3, 4 and 5 (including any amendments, supplements or exhibits
 thereto) in accordance with Section 16(a) of the Securities Exchange
 Act of 1934 and the rules thereunder; (ii) do and perform any and
 all acts for and on behalf of the undersigned which may be necessary
 or desirable to complete and execute any such Form 3, 4 or 5
 (including any amendments, supplements or exhibits thereto)
 and timely file such form with the United States Securities
 and Exchange Commission (the SEC) and any stock exchange or
 similar authority, including the New York Stock Exchange, and
 including without limitation the filing of a Form ID or any
 other documents necessary or appropriate to enable the undersigned
 to file the Form 3, 4 and 5 electronically with the SEC; (iii)
 seek or obtain, as the undersigneds representative and on the
 undersigneds behalf, information on transactions in the Companys
 securities from any third party, including brokers, employee
 benefit plan administrators and trustees, and the undersigned
 hereby authorizes any such person to release any such
 information to each of the undersigneds attorneys-in-fact
 appointed by this Power of Attorney and ratifies any such
 release of information; and (iv) take any other action
 of any type whatsoever in connection with the foregoing which,
 in the opinion of such attorney-in-fact, may be of benefit to,
 in the best interest of, or legally required by, the undersigned,
 it being understood that the documents executed by such attorney-in-fact
 on behalf of the undersigned pursuant to this Power of Attorney shall be
 in such form and shall contain such terms and conditions as such
 attorney-in-fact may approve in such attorney-in-facts discretion.

 The undersigned hereby grants to each such attorney-in-fact full
 power and authority to do and perform any and every act and thing
 whatsoever requisite, necessary or proper to be done in the exercise
 of any of the rights and powers herein granted, as fully to all
 intents and purposes as the undersigned might or could do if personally
 present, with full power of substitution or revocation, hereby ratifying
 and confirming all that such attorney-in-fact, or such attorney-in-facts
 substitute or substitutes, shall lawfully do or cause to be done by virtue
 of this power of attorney and the rights and powers herein granted.
 The undersigned acknowledges that the foregoing attorneys-in-fact,
 in serving in such capacity at the request of the undersigned, are not
 assuming, nor is the Company assuming, any of the undersigneds
 responsibilities to comply with Section 16 of the Securities
 Exchange Act of 1934.

 This Power of Attorney shall remain in full force and effect until
 the undersigned is no longer required to file Forms 3, 4 and 5 with
 respect to the undersigneds holdings of  and transactions in securities
 issued by the Company, unless earlier revoked by the undersigned in
 a signed writing delivered to the foregoing attorneys-in-fact.

 IN WITNESS WHEREOF, the undersigned has caused this Power of
 Attorney to be executed as of date first written above.


Signed and acknowledged:

/s/ Christopher L. Grashoff